Long-term study of individuals taking Vioxx (rofecoxib) for arthritis and chronic pain has confirmed some bad news associated with the painkiller but it has revealed some good news, too.  Vioxx, a Cox-2 inhibitor class of drug, was pulled from the…

Osteoarthritis is thought to affect at least 21 million Americans, oftentimes bringing crippling pain and limited mobility.  To relieve the pain and slow the progression of the disease, many people turn to glucosamine and chondroitin sulfate supplements but a recent…

Many people suffering from osteoarthritis of the hip rely on their daily dose of glucosamine to help them make it smoothly and painlessly through the day. A recent study suggests the glucosamine might not be that effective after all.

…